Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Forge Announces Visible Gold & Continued Porphyry Mineralization at Alotta Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio...
includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
raybay_98
X
Comment by
raybay_98
on Jul 11, 2024 12:37pm
RE:RE:RE:Not Much for Sale
And once again, your out to lunch as the saying goes! JMHO
(6241)
•••
retiredcf
X
Comment by
retiredcf
on Jul 11, 2024 10:35am
RE:RE:Not Much for Sale
Just like the last couple of days, it looks like the SP is being walked down in 100 share increments to the large bid sitting at $12.00. Only 30% of that bid would blow out all 10 visible levels
...more
(69)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Jul 10, 2024 1:59pm
RE:Not Much for Sale
Never-ending offer from RBC. IMHO stock will spring if and when that ends.
(6241)
•••
retiredcf
X
Post by
retiredcf
on Jul 10, 2024 9:47am
Not Much for Sale
Only 2800 total over 10 levels of Asks up to $13.10 so things have definitely calmed down. GLTA
(7)
•••
sunshine7
X
Comment by
sunshine7
on Jul 09, 2024 8:28pm
RE:Opened a small position
Same here. I think enough info was provided to allay fears of further downside and looking forward to better days and weeks ahead.
(80)
•••
BlueJay2020
X
Post by
BlueJay2020
on Jul 09, 2024 3:33pm
Opened a small position
Hi folks I opened a small position today and will continue to add. Like others, I see an overreaction to this news. Yes, there could be another shoe to drop but otherwise the thesis is
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Jul 09, 2024 12:16pm
New Press Release - Kalloghlian Myers LLP: Potential Investor Class Action Against DRI Healthcare Trust
Kalloghlian Myers LLP is investigating a potential investor class action against DRI Healthcare Trust (the “Trust”) (TSX: DHT.UN) (TSX: DHT.U) and certain current and former trustees and officers. On July 8, 2024, the Trust announced the resignation of Behzad Khosrowshahi as trustee and CEO as a...
read article.
(6241)
•••
retiredcf
X
Post by
retiredcf
on Jul 09, 2024 11:31am
RBC Report
Their upside scenario target is now $20.00. GLTA July 8, 2024 Outperform TSX: DHT-U; CAD 11.17 Price Target CAD 16.00 ↓ 20.00
...more
(13)
•••
SuperM
X
Post by
SuperM
on Jul 09, 2024 11:22am
More analysts chime in
Elsewhere, CIBC cut its target price to C$18.5 from C$20; RBC cut its target price to C$16 from C$20; and Stifel cut its target price to C$15 from C$22 while downgrading its rating to “hold” from “buy
...more
(6)
•••
Terek8
X
Comment by
Terek8
on Jul 09, 2024 11:06am
RE:More National Bank + Raymond James
surprising non of the analyst did not comment in the past about these expenses and finally the ownership summary looks like to many hands in the cookie jar
(1)
•••
Bamsmba
X
Comment by
Bamsmba
on Jul 09, 2024 10:53am
RE:RE:RE:RE:RE:Time to bring management in house
You got it, Retiredcf... you provide more value to this BB... than anyone I have seen. I got out of this stock before it time to buy!
(69)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Jul 09, 2024 10:26am
RE:Clear legal Cause to Terminate DRI Capital / Persis
Leverage! IMHO a huge buying opportunity. As I said elsewhere, trustees will need a huge concession from the manager to be seen to meet their fiduciary obligations. Gary was in government
...more
(69)
•••
SONOFFERGUS
X
Comment by
SONOFFERGUS
on Jul 09, 2024 9:59am
RE:CIBC
Thanks for this retiredcf! I'm not a lawyer, but my expectation is that Gary and the other trustees will be sweating their fiduciary obligations to unitholders. A prudent trustee would be
...more
(6241)
•••
retiredcf
X
Post by
retiredcf
on Jul 09, 2024 9:30am
More National Bank + Raymond James
Executive changes at DRI Healthcare Trust on the back of a misconduct investigation have National Bank Financial analyst Zachary Evershed slashing his price target on the stock.
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Canadian clean tech company pioneering the upcycling of used motor oil into high value Group III base oils
A Canadian mineral company at the crossroads of electrification and defense
Gold rush 2025: Why Desert Gold Ventures Inc. is now on the brink of a historic revaluation!
Maiden Resource Estimate of 54 Moz at 284 gpt Silver, Highlights High-Grade Potential at Columba